These infographics cover the latest information on the role of BTK inhibitors in the treatment of B-cell malignancies, specifically at the mechanisms of action across the different BTKis, the safety/efficacy profiles of these molecules, and any potential adverse effects and toxicities associated with the prolonged use of BTKis, as well as how to identify early signs of resistance and treatment failure and understand potential mechanisms of resistance to adapt treatment plans accordingly.
